U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512414) titled 'Simulation-based Pediatric Nursing Laboratory Education' on Dec. 27, 2025. Brief Summary: ... Read More
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511881) titled 'Far-UVC and Infections in Long-term Care Facilities' on March 30. Brief Summary: Backgroun... Read More
Nigeria, April 7 -- The Nigerian government has opened discussions with European aerospace manufacturer Airbus to develop a nationwide ground-to-air emergency medical response system. The Coordinatin... Read More
India, April 7 -- SKF is consolidating its manufacturing footprint in the Americas as part of the ongoing separation of its Automotive business. The move is designed to strengthen long-term efficiency... Read More
New Delhi, April 7 -- Indian playback singer Shreya Ghoshal, along with her mother Shamishtha Ghoshal and father Biswajit Ghoshal, has purchased an apartment in Worli, Mumbai, for Rs. 29.70 crore, acc... Read More
Sri Lanka, April 7 -- Iranians have gathered in large numbers at bridges and power generation stations across the country, forming human chains to prevent them from being targeted, the country's state... Read More
New Delhi, April 7 -- New Delhi [India], April 07 : Adding to the string of academic triumphs, Ms. Haniya Khan, an MBA first semester student from IPS Academy, IBMR North Campus - a DAVV-affili... Read More
India, April 7 -- Mach Natural Resources LP (MNR) shares fell 10.24 percent, down $1.45 to $12.70 on Tuesday, after selling unitholders priced an underwritten public offering of 9 million common units... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More